KALV: KalVista Pharmaceuticals Inc

14.52 USD 0.36 (2.42%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do KALV para hoje mudou para -2.42%. Paralelamente, o preço mais baixo no mercado atingiu 13.85 e o mais alto foi 14.99.

Veja a dinâmica do par de moedas KalVista Pharmaceuticals Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

KALV Notícias

Investing 11:25 Kalvista stock maintains Buy rating at H.C. Wainwright on favorable Ekterly label
Investing 01:01 Kalvista Pharma CEO Palleiko sells $517k in shares
Investing 00:52 Kalvista Pharma chief development officer sells $474k in shares
Investing 15:15 Leerink Partners reiterates Outperform rating on Kalvista stock as Ekterly launch begins
Seeking Alpha 19:52 KalVista: FDA Approval Of EKTERLY As Oral On-Demand HAE Drug Is Just Beginning (KALV)
Benzinga 14:03 Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR)
Investing 08:53 Kalvista stock price target raised to $27 from $19 at JMP on Ekterly pricing
Investing 19:27 Kalvista stock rises as Leerink raises price target on FDA approval
Investing 18:01 Tesla, Circle Internet Surge Among Monday’s Market Cap Stock Movers
Investing 17:11 KalVista stock price target raised to $37 from $22 at BofA on Ekterly approval
Investing 14:36 Kalvista stock jumps as Stifel reiterates Buy rating on Ekterly approval
Investing 14:31 Tesla, Oracle among Monday’s market cap stock movers
Benzinga 14:05 KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday - Amber International (NASDAQ:AMBR), Baidu (NASDAQ:BIDU)
Investor's Business Daily 13:12 KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment
Investing 12:22 US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
Benzinga 11:47 Why Is KalVista Pharmaceuticals Stock Soaring On Monday? - KalVista Pharma (NASDAQ:KALV)
Investing 11:26 KalVista stock soars after FDA approves first oral HAE treatment
Investing 10:37 FDA approves KalVista’s oral HAE treatment Ekterly
Investing 11:08 KalVista grants Pendopharm exclusive rights for sebetralstat in Canada
Investing 20:36 Kalvista stock volatile after report of FDA commissioner intervention
Investor's Business Daily 12:02 How KalVista Pharma Is Taking On A Rare But Deadly Disease
Investing 12:15 FDA delays Kalvista’s sebetralstat decision due to resource constraints
Investing 11:09 KalVista’s oral HAE treatment shows efficacy for breakthrough attacks
Investing 09:08 Kalvista stock steady as JMP reiterates $19 target amid FDA delay

Faixa diária

13.85 14.99

Faixa anual

7.31 16.32

Fechamento anterior: 15.51
Open: 14.88

Bid: 14.52
Ask: 14.82

Low: 13.85
High: 14.99

Volume: 5.171 K

Mudança diária: -2.42%
Mudança mensal: 29.07%

Mudança de 6 meses: 65.75%
Mudança anual: -2.16%

12 julho, sábado